glp-1 with medicaid McKee's proposed FY2027 budget drops drugs for weight loss from • Rhode Island Current State-by-State Divide Over GLP-1 Medicaid

Now, research has shown that GLP-1 in higher dosages signals a feeling of fullness to cause significant weight loss and reduce the risk of cancer, diabetes, and heart disease in overweight individuals

Some studies found that LDL-C levels significantly reduced following treatment with liraglutide 1.2 mg/day or 1.8 mg/day (-0.28 and -0.23 mmol/L), exenatide once weekly (-0.13 and -0.17 mmol/L), and exenatide twice daily (-0.25 mmol/L and -6% change from baseline) [66]

10.1016/j.bbrc.2021.02.065 93 ZhangZ.MaY.XieC.HeY.WangD.SongH.et al (2025)

These projections are in comparison to actual GLP-1 weight loss spending of approximately $8 million in 2021, $19 million in 2022, and $62 million in 2023

Obesity (Silver Spring, Md.), 33(9), 16571667

It is sweetened with stevia